Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Share by Ken Dropiewski on January 22, 2019 More in Financial: Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 April 15, 2026 Bunkerhill Health Secures CMS Reimbursement Pathway for AI Cardiovascular Analysis, Receives FDA Clearance for the First AI Algorithms to Evaluate Coronary and Aortic Valve Calcium on Contrast-Enhanced Chest CTs April 15, 2026 Stereotaxis Announces Definitive Agreement to Acquire Robocath April 15, 2026 Share this story Facebook Twitter LinkedIn